OMA1 reprograms metabolism under hypoxia to promote colorectal cancer development
- PMID: 33314701
- PMCID: PMC7788456
- DOI: 10.15252/embr.202050827
OMA1 reprograms metabolism under hypoxia to promote colorectal cancer development
Abstract
Many cancer cells maintain enhanced aerobic glycolysis due to irreversible defective mitochondrial oxidative phosphorylation (OXPHOS). This phenomenon, known as the Warburg effect, is recently challenged because most cancer cells maintain OXPHOS. However, how cancer cells coordinate glycolysis and OXPHOS remains largely unknown. Here, we demonstrate that OMA1, a stress-activated mitochondrial protease, promotes colorectal cancer development by driving metabolic reprogramming. OMA1 knockout suppresses colorectal cancer development in AOM/DSS and xenograft mice models of colorectal cancer. OMA1-OPA1 axis is activated by hypoxia, increasing mitochondrial ROS to stabilize HIF-1α, thereby promoting glycolysis in colorectal cancer cells. On the other hand, under hypoxia, OMA1 depletion promotes accumulation of NDUFB5, NDUFB6, NDUFA4, and COX4L1, supporting that OMA1 suppresses OXPHOS in colorectal cancer. Therefore, our findings support a role for OMA1 in coordination of glycolysis and OXPHOS to promote colorectal cancer development and highlight OMA1 as a potential target for colorectal cancer therapy.
Keywords: OMA1; colorectal cancer; glycolysis; hypoxia; oxidative phosphorylation.
© 2020 The Authors.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures
Similar articles
-
The mitochondrial protease OMA1 acts as a metabolic safeguard upon nuclear DNA damage.Cell Rep. 2023 Apr 25;42(4):112332. doi: 10.1016/j.celrep.2023.112332. Epub 2023 Mar 31. Cell Rep. 2023. PMID: 37002921
-
Nutrient deprivation-related OXPHOS/glycolysis interconversion via HIF-1α/C-MYC pathway in U251 cells.Tumour Biol. 2016 May;37(5):6661-71. doi: 10.1007/s13277-015-4479-7. Epub 2015 Dec 8. Tumour Biol. 2016. PMID: 26646563
-
The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism.Cancer Lett. 2015 Jan 28;356(2 Pt A):156-64. doi: 10.1016/j.canlet.2014.04.001. Epub 2014 Apr 13. Cancer Lett. 2015. PMID: 24732809 Free PMC article. Review.
-
Mitochondrial UQCC3 Modulates Hypoxia Adaptation by Orchestrating OXPHOS and Glycolysis in Hepatocellular Carcinoma.Cell Rep. 2020 Nov 3;33(5):108340. doi: 10.1016/j.celrep.2020.108340. Cell Rep. 2020. PMID: 33147459
-
HIF-1-Dependent Reprogramming of Glucose Metabolic Pathway of Cancer Cells and Its Therapeutic Significance.Int J Mol Sci. 2019 Jan 9;20(2):238. doi: 10.3390/ijms20020238. Int J Mol Sci. 2019. PMID: 30634433 Free PMC article. Review.
Cited by
-
Inorganic Polyphosphate Promotes Colorectal Cancer Growth via TRPM8 Receptor Signaling Pathway.Cancers (Basel). 2024 Sep 28;16(19):3326. doi: 10.3390/cancers16193326. Cancers (Basel). 2024. PMID: 39409946 Free PMC article.
-
Construction and validation of a pancreatic cancer prognostic model based on genes related to the hypoxic tumor microenvironment.World J Gastroenterol. 2024 Sep 28;30(36):4057-4070. doi: 10.3748/wjg.v30.i36.4057. World J Gastroenterol. 2024. PMID: 39351249 Free PMC article.
-
Targeting DNM1L/DRP1-FIS1 axis inhibits high-grade glioma progression by impeding mitochondrial respiratory cristae remodeling.J Exp Clin Cancer Res. 2024 Sep 30;43(1):273. doi: 10.1186/s13046-024-03194-6. J Exp Clin Cancer Res. 2024. PMID: 39350223 Free PMC article.
-
Opa1 processing is dispensable in mouse development but is protective in mitochondrial cardiomyopathy.Sci Adv. 2024 Aug 2;10(31):eadp0443. doi: 10.1126/sciadv.adp0443. Epub 2024 Aug 2. Sci Adv. 2024. PMID: 39093974 Free PMC article.
-
Identification of TEFM as a potential therapeutic target for LUAD treatment.J Transl Med. 2024 Jul 29;22(1):692. doi: 10.1186/s12967-024-05483-2. J Transl Med. 2024. PMID: 39075464 Free PMC article.
References
-
- Acín‐Pérez R, Fernández‐Silva P, Peleato ML, Pérez‐Martos A, Enriquez JA (2008) Respiratory active mitochondrial supercomplexes. Mol Cell 32: 529–539 - PubMed
-
- Acin‐Perez R, Lechuga‐Vieco AV, Del Mar MM, Nieto‐Arellano R, Torroja C, Sánchez‐Cabo F, Jiménez C, González‐Guerra A, Carrascoso I, Benincá C et al (2018) Ablation of the stress protease OMA1 protects against heart failure in mice. Sci Transl Med 10: eaan4935 - PubMed
-
- Alavi MV (2019) Targeted OMA1 therapies for cancer. Int J Cancer 145: 2330–2341 - PubMed
-
- Amini MA, Karimi J, Khodadadi I, Tavilani H, Talebi SS, Afshar B (2019) Overexpression of ROMO1 and OMA1 are potentially biomarkers and predict unfavorable prognosis in gastric cancer. J Gastrointest Cancer 51: 939–946 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical